At the end of 2023, we compiled a list of the 10 biggest diabetes technology stories of the year. Some of those stories didn’t end in 2023, though, as a few major product launches loom on the horizon.
New CGMs, insulin pumps and combinations of the two will all be coming to the market over the next several months. Here are some of the most highly-anticipated product launches set to take place in the diabetes space in 2024 — plus some of the tech that’s already launched:
Diabetes launches on the horizon
Medtronic’s new pump-sensor combo
In January, Medtronic won CE mark for its MiniMed 780G automated insulin delivery system with the Simplera Sync sensor.
MiniMed 780G, an automated insulin delivery system, offers meal detection technology and provides automatic adjustments and corrections to sugar levels every five minutes. This occurs for both basal (background) and bolus (mealtime) insulin needs. The system already has commercial availability in geographies including the U.S. and Europe in tandem with the Guardian 4 sensor.
Medtronic plans to make MiniMed 780G with Simplera Sync available in Europe through a limited release in spring 2024. It then expects a phased commercial launch in the summer of 2024. While still investigational in the U.S., the combination could still see a stateside launch if clearance comes soon enough.
The company also began rolling out its InPen smart insulin pen system with Simplera in Europe at the end of last year.
Get the full story at our sister site, Drug Delivery Business News.
